Anika Therapeutics (ANIK) Q2 2026 Earnings

29AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.26
-0.09
0.09
0.27

Details

Expected EPS
-0.07
Actual EPS
0.27
Surprise EPS
0.34
Surprise Percent
+485.71%

Description

Anika Therapeutics (ANIK) has reported earnings of 0.27 per share for Q2 2026.

0 Comments

Share your thoughts